Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 12, 2008, Pages 4377-4385

  Nordentoft, I ^a   Jeppesen, P B ^a   Hong, J ^a   Abudula, R ^a   Hermansen, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Beta cell transcription factors; Insulin sensitizer; Islet proliferation; Islets; KKAy mice; Microarray; Real time RT PCR; Soy bean isolate; T2DM

Indexed keywords

INSULIN; ISOFLAVONE DERIVATIVE; LIPID; SOYBEAN PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMISTRY; DIET; GENE EXPRESSION PROFILING; GENETICS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; GENE EXPRESSION PROFILING; INSULIN; INSULIN-SECRETING CELLS; ISOFLAVONES; LIPIDS; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOYBEAN PROTEINS; TRANSCRIPTION FACTORS;

ANIMALIA; GLYCINE MAX; MUS;

EID: 47349121662     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800504r     Document Type: Article

References (36)

1. Isomaa, B.; Almgren, P.; Tuomi, T.; Forsen, B.; Lahti, K.; Nissen, M.; Taskinen, M. R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 Apr;, 24 (4), 683-9.
2. Lakka, H. M.; Laaksonen, D. E.; Lakka, T. A.; Niskanen, L. K.; Kumpusalo, E.; Tuomilehto, J.; Salonen, J. T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 Dec 4, 288 (21), 2709-16.
3. Lichtenstein, A. H.; Kennedy, E.; Barrier, P.; Danford, D.; Ernst, N. D.; Grundy, S. M.; Leveille, G. A.; Van, H. L.; Williams, C. L.; Booth, S. L. Dietary fat consumption and health. Nutr.Rev. 1998 May;, 56 (5 Pt 2), S3-19.
4. Sacks, F. M.; Lichtenstein, A.; Van, H. L.; Harris, W.; Kris-Etherton, P.; Winston, M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006 Feb 21, 113 (7), 1034-44.
5. Sirtori, C. R.; Gatti, E.; Mantero, O.; Conti, F.; Agradi, E.; Tremoli, E.; Sirtori, M.; Fraterrigo, L.; Tavazzi, L.; Kritchevsky, D. Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia. Am. J. Clin. Nutr. 1979 Aug, 32 (8), 1645-58.
6. Descovich, G. C.; Ceredi, C.; Gaddi, A.; Benassi, M. S.; Mannino, G.; Colombo, L.; Cattin, L.; Fontana, G.; Senin, U.; Mannarino, E.; et al. Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients. Lancet 1980 Oct 4, 2 (8197), 709-12.
7. Anderson, J. W.; Johnstone, B. M.; Cook-Newell, M. E. Meta-analysis of the effects of soy protein intake on serum lipids. N.Engl.J.Med. 1995 Aug 3, 333 (5), 276-82.
8. Hermansen, K.; Sondergaard, M.; Hoie, L.; Carstensen, M.; Brock, B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001 Feb, 24 (2), 228-33.
9. Merritt, J. C. Metabolic syndrome: soybean foods and lipids. J Natl Med Assoc. 2004 Aug, 96 (8), 1032-41.
10. Anderson, R. L.; Wolf, W. J. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 1995 Mar, 125 (3 Suppl), 581S-588S.
11. Dyrskog, S. E.; Jeppesen, P. B.; Colombo, M.; Abudula, R.; Hermansen, K. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism 2005 Sep, 54 (9), 1181-8.
12. Jeppesen, P. B.; Dyrskog, S. E.; Agger, A.; Gregersen, S.; Colombo, M.; Xiao, J.; Hermansen, K. Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat. Rev.Diabet.Stud. 2006, 3 (4)), 189-99.
13. Heding, L. G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972 Aug, 8 (4), 260-6.
14. Chang, J. C.; Wu, M. C.; Liu, I. M.; Cheng, J. T. Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm.Metab Res. 2005 Oct, 37 (10), 610-6.
15. Habener, J. F.; Kemp, D. M.; Thomas, M. K. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005 Mar, 146 (3), 1025-34.
16. Malecki, M. T.; Jhala, U. S.; Antonellis, A.; Fields, L.; Doria, A.; Orban, T.; Saad, M.; Warram, J. H.; Montminy, M.; Krolewski, A. S. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat. Genet. 1999 Nov, 23 (3), 323-8.
17. Rader, D. J. Mechanisms of disease: HDL metabolism as a target for novel therapies. Nat.Clin.Pract.Cardiovasc.Med. 2007 Feb, 4 (2), 102-9.
18. Efrat, S. Making sense of glucose sensing. Nat. Genet. 1997 Nov, 17 (3), 249-50.
19. Guillam, M. T.; Dupraz, P.; Thorens, B. Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes 2000 Sep, 49 (9), 1485-91.
20. Terauchi, Y.; Sakura, H.; Yasuda, K.; Iwamoto, K.; Takahashi, N.; Ito, K.; Kasai, H.; Suzuki, H.; Ueda, O.; Kamada, N,.; et al. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem. 1995Dec 22;, 270 (51), 30253-6.
21. Terauchi, Y.; Takamoto, I.; Kubota, N.; Matsui, J.; Suzuki, R.; Komeda, K.; Hara, A.; Toyoda, Y.; Miwa, I.; Aizawa, S.; et al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J.Clin.Invest 2007Jan;, 117 (1), 246-57.
22. Aramata, S.; Han, S. I.; Yasuda, K.; Kataoka, K. Biochim.Biophys. Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim. Biophys. Acta 2005Jul 25;, 1730 (1), :41-6.
23. memiya-Kudo M,; Oka, J.; Ide, T.; Matsuzaka, T.; Sone, H.; Yoshikawa, T.; Yahagi, N.; Ishibashi, S.; Osuga, J.; Yamada, N, et al. Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. J. Biol. Chem. 2005Oct 14;, 280 (41), 34577-89.
24. Lu, Y.; Ponton, A.; Okamoto, H.; Takasawa, S.; Herrera, P. L.; Liu, J. L. Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas. Am.J.Physiol Endocrinol.Metab 2006 Jul;, 291 (1), :E50-E58.
25. Lu, Y.; Herrera, P. L.; Guo, Y.; Sun, D.; Tang, Z.; LeRoith, D.; Liu, J. L. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 2004, Dec, 53 (12), :3131-41.
26. Grupping, A. Y.; Cnop, M.; Van Schravendijk, C. F.; Hannaert, J. C.; Van Berkel, T. J.; Pipeleers, D. G. Low density lipoprotein binding and uptake by human and rat islet beta cells. Endocrinology 1997 Oct;, 138 (10), 4064-8.
27. Cnop, M.; Hannaert, J. C.; Grupping, A. Y.; Pipeleers, D. G. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology 2002Sep;, 143 (9), 3449-53.
28. Hermansen, K. Effects of cholecystokinin (CCK): - 4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. Endocrinology 1984May;, 114 (5), 1770-5.
29. Simonsson, E.; Karlsson, S.; Ahren, B. Islet phospholipase A(2) activation is potentiated in insulin resistant mice. Biochem. Biophys. Res. Commun. 2000 Jun 7;, 272 (2), 539-43.
30. Myrsen-Axcrona, U.; Ekblad, E.; Sundler, F. Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones. Regul. Pept. 1997 Feb 26, 68 (3), 165-75.
31. Rulifson, I. C.; Karnik, S. K.; Heiser, P. W.; Ten BD, Chen.; H, Gu.; X, Taketo.; MM, Nusse.; R, Hebrok.; M, Kim.; SK. Wnt signaling regulates pancreatic beta cell proliferation. Proc.Natl.Acad.Sci.U.S.A 2007Apr 10;, 104 (15), 6247-52.
32. Kushner, JA,.; Ciemerych, MA,.; Sicinska, E,.; Wartschow, LM,.; Teta, M,.; Long, SY,.; Sicinski, P. White MF. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell. Biol. 2005 May, 25 (9), 3752-62.
33. Georgia, S.; Bhushan, A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J.Clin.Invest 2004 Oct, 114 (7), 963-8.
34. Ogawa, W. [Current advance in insulin signal transduction]. Nippon Rinsho 2001 Sep, 59, (9), 1847-55.
35. Vedavanam, K.; Srijayanta, S.; O'Reilly, J.; Raman, A.; Wiseman, H. Phytother.Res. 1999 Nov;, 13 (7), 601-8.
36. Lee, S. O.; Simons, A. L.; Murphy, P. A.; Hendrich, S. Soyasaponins lowered plasma cholesterol and increased fecal bile acids in female golden Syrian hamsters. Exp Biol Med (Maywood) 2005 Jul, 230 (7), 472-8.